CHEMOTHERAPY/ ANTICANCER DRUGS/ NEOPLASTIC AGENTS

Size: px
Start display at page:

Download "CHEMOTHERAPY/ ANTICANCER DRUGS/ NEOPLASTIC AGENTS"

Transcription

1 CHEMOTHERAPY/ 1 Oncology, Misc, Vaccines ANTICANCER DRUGS/ NEOPLASTIC AGENTS Important Terms: Cancer: A group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. Neoplasia: Uncontrolled growth of new tissue, the product of which is known as a tumour, and these tumours may be either malignant or benign. Malignant tumours: have the capability of invading surrounding tissues and moving to distant locations in the body in a process known as metastasis; characteristics that benign tumours do not possess. Chemotherapy: Drugs that are used to kill cells and includes both antibiotics and agents used in the treatment of cancer. Autocrine signalling: Cells may acquire the ability to synthesize their own growth factors Apoptosis: programmed cell death Apoptosome: apoptotic protease activating factor-1 (apaf-1) molecules to form a wheel-like structure of seven spokes. Drugs are used with the aim of: Cure or prolonged remission, Palliation, Adjuvant chemotherapy Treatment: o Surgery o Chemotherapy o Radiation Therapy o Hormonal Therapy o Targeted Therapy o Palliative Care Classification: [Pneumonic: AAP MATT] A. Cytotoxic Drugs 1. Alkylating agents[pmemonic: NAMENT] Nitrogen mustards: Mechlorethamine (Mustine HCl), Cyclophosphamide, Ifosfamide, Chlorambucil, Melphalan

2 3 Oncology, Misc, Vaccines C. Hormonal Drugs 1. Glucocorticoids: Prednisolone and Others 2. Estrogens: Fosfestrol, Ethinylestradiol 3. Selective Estrogen Receptor Modulators: Tamoxifen, Toremifene 4. Selective Estrogen Receptor Down Regulators: Fulvestrant 5. Aromatase Inhibitors: Letrozole, Anastrozole, Exemestane 6. Antiandrogen: Flutamide, Bicalutamide 7. 5:Α Reductase Inhibitor: Finasteride, Dutasteride 8. GnRH Analogues: Nafarelin, Leuprorelin, Triptorelin 9. Progestins: Hydroxyprogesterone Acetate etc. Based On Step of Cell Cycle Action I.Cell Cycle Nonspecific Kill Resting As Well As Dividing Cells Eg. Nitrogen Mustard, Cyclophosphamide, Chlorambucil, Carmustine, Dacarbazine, Busulfan, L- Asparaginase, Cisplatin, Procarbazine, Actinomvcin D II.Cell Cycle Specific- Kill Only Actively Dividing Cells o Their toxicity is generally expressed in s phase. o These drugs may show considerable phase selectivity, G 1 : Vinblastine S: Mtx, Cytarabine, 6-TG, 6-MP, 5-FU, Hydroxyurea, Mitomycin C, Doxorubicin, Daunorubicin G 2 : Daunorubicin, Bleomycin, Etoposide, Topotecan. [Pneumonic: DTEB] M: Vincristine, Vinblastine, Paclitaxel, Docetaxel [Pneumonic: VT]

3 4 Oncology, Misc, Vaccines Toxicity of Cytotoxic Drugs: Bone marrow Depression of bone marrow results in granulocytopenia, agranulocytosis, thrombocytopenia, aplastic anaemia GIT: Drugs cause mucositis are-bleomycin, Actinomycin D, Daunorubicin, Doxorubicin, Fluorouracil and Methotrexate. Drugs causing emesis: Cisplatin, Mustine, Cyclophosphamide, Actinomycin D, Dacarbazine, Lomustine Skin: Alopecia Gonads: Inhibition of gonadal cells causes oligozoospermia and impotence in males; inhibition of ovulation and amenorrhoea are common in females. Foetus: Teratogenesis Carcinogenicity Hyperuricaemia: Gout, urate stones, Allopurinol is protective by decreasing uric acid synthesis. Individual drug toxicity: o Neuropathy by Vincristine o Cardiomyopathy by Doxorubicin o Cystitis and Alopecia by Cyclophosphamide Individual Drugs Alkylating Agents: Produce highly reactive carbonium ion intermediates which transfer alkyl group to cellular macro-molecules by forming covalent bonds. Position 7 of guanine residues in DNA is more susceptible. Alkylation cause cross linking/abnormal base pairing/ scission of DNA strand

4 5 Oncology, Misc, Vaccines Nitrogen mustards- Nitrogen mustards are compounds similar to sulfur mustard or mustard gas developed and used in World War I. Mechlorethamine (Mustine HCl) Nitrogen mustard; highly reactive and local vesicant Only by i.v. route. Antidote: Sodium thiosulfate Cyclophosphamide Inactive, transformation into active metabolites (aldophosphamide, phosphoramide mustard) occurs in the liver Prominent immunosuppressant property Alopecia and cystitis (due to acrolein) are prominent. Chloramphenicol retards the metabolism of cyclophosphamide. Metabolic and activation of Cyclophosphamide Ifosfamide: Dose limiting toxicity is haemorrhagic cystitis. Rescue agent MESNA given. R-isomer is converted to the required 4-hydroxy-ifosfamide 2 to 3 times faster than the S-isomer MESNA [Sodium methanethiolate, Sodium 2-sulfanylethane sulfonate, 2-Mercaptoethane Sulfonate Sodium]

5 7 Oncology, Misc, Vaccines Ethylenimine- Thio-TEPA: TEPA Metabolic and chemical interactions of thiotepa with DNA Alkylsulfonate: Busulfan Hyperuricaemia, sterility. Drug of choice for chronic myeloid leukaemia Nitrosoureas: Carmustine (BCNU) Highly lipid soluble alkylating agents with a wide range of antitumor activity Cross blood-brain barrier Lomustine (CCNU) Dacarbazine (DTIC): Inhibitory action on RNA and protein synthesis (others mainly affect DNA)

6 Resistance: mismatch pair, decreased uptake Toxicity: Renal impairment, tinnitus, deafness, neuropathy, hyperuricaemia 9 Oncology, Misc, Vaccines Carboplatin Less reactive, better tolerated due to cyclic ring(1,1cyclobutane dicarboxylate) Rescue Agent: chelat 1, 1-cyclobutane-dicarboxylate Toxicity: Nephrotoxicity, ototoxicity and neurotoxicity are low. Dose-limiting toxicity is thrombocytopenia and leucopenia. Satraplatin: orally active Mechanism of cisplatin activation and formation of DNA adducts Antimetabolites: Analogues related to normal components of DNA or of coenzymes involved in nucleic acid synthesis. Competitively inhibit utilization of the normal substrate or get themselves incorporated forming dysfunctional macromolecules Folate antagonist: Methotrexate (Mtx) Oldest and highly efficacious anti-neoplastic drugs

7 10 Oncology, Misc, Vaccines Inhibits dihydrofolate reductase (DHFRase) block the conversion of dihydrofolic acid (DHFA) to tetra hydrofolic acid (THFA), an essential coenzyme required for one carbon transfer reactions in de-novo purine synthesis and amino acid inter-conversions. Inhibition is pseudo-irreversible because Mtx has 50,000 times higher affinity for the enzyme than the normal substrate. Methotrexate has cell cycle specific action kills cells in S phase; primarily inhibits DNA synthesis. Toxicity: Megaloblastic anaemia, pancytopenia Methotrexate excreted unchanged in urine. Salicylates, sulfonamides, dicumerol displace it from protein binding sites. Aspirin and sulfonamides enhance toxicity of Mtx by decreasing its renal tubular secretion. Amelioration: By folic acid, because it will not be converted to the active coenzyme form. Folinic acid (N5 formyl THFA, cirtrovorum factor) rapidly reverses the effects. Use of folinic acid rescue has permitted much higher doses of Mtx (100 times higher dose) Calcium leucovorin followed within 3 hours, repeated as required. Thymidine also counteracts Mtx toxicity. Highly effective in maintaining remission in children with acute leukemia s, malignancies, rheumatoid, athritis, psoriasis and as immunosuppressant.. Purine antagonist: 6-Mercaptopurine (6-MP) Converted in the body to mono ribonucleotides which inhibit the conversion of inosine monophosphate to adenine and guanine nucleotides

2. Mitotic Spindle Inhibitors (modulators of tubulin polymerisation) 3. Antimetabolites (anti-folates, pyrimidine and purine analogues)

2. Mitotic Spindle Inhibitors (modulators of tubulin polymerisation) 3. Antimetabolites (anti-folates, pyrimidine and purine analogues) CANCER DRUG CLASSES The classes of drugs currently used in the cancer clinic are 1. DNA Binding Agents (intercalating and alkylating agents) 2. Mitotic Spindle Inhibitors (modulators of tubulin polymerisation)

More information

Cancer Chemotherapy. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018

Cancer Chemotherapy. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018 Cancer Chemotherapy Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018 االدوية Polyfunctional Alkylating Agents االستخالبية متعددة الوظائف Not cell cycle-specific.

More information

Year III Pharm D. Dr. V. Chitra

Year III Pharm D. Dr. V. Chitra Year III Pharm D. Dr. V. Chitra 50.2 Rang Etiolopathology Cell Cycle = Growth, Division 18_01_cell_cycle.jpg Characteristics of Cancer Cells The problem: Cancer cells divide rapidly (cell cycle is accelerated)

More information

Anti-cancer drugs. Introduction : Body : 1) Alkylating Agents

Anti-cancer drugs. Introduction : Body : 1) Alkylating Agents Anti-cancer drugs Introduction : In this journal I will try to explain what is anti-cancer agents, how they work, how can they inhibit the growth of tumor and what is the advantages and disadvantages of

More information

Medication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC

Medication Review. Cancer Chemotherapy Drugs. Pharmacy Technician Training Systems Passassured, LLC Medication Review Cancer Chemotherapy Drugs Pharmacy Technician Training Systems Passassured, LLC Medication Review, Cancer Chemotherapy Drugs PassAssured's Pharmacy Technician Training Program Medication

More information

DRUGS YOU NEED TO KNOW

DRUGS YOU NEED TO KNOW jfitzake@d.umn.edu Page 1 of 7 DRUGS YOU NEED TO KNOW ALKYLATING AGENTS (blue cards) BUSULFAN CARMUSTINE (BCNU) CYCLOPHOSPHAMIDE DACARBAZINE LOMUSTINE (CCNU) MECHLORETHAMINE MELPHALAN THIOTEPA NATURAL

More information

Anticancer Drugs. Cytotoxic drugs Antineoplastic agents

Anticancer Drugs. Cytotoxic drugs Antineoplastic agents Anticancer Drugs Cytotoxic drugs Antineoplastic agents 1 Principles of Cancer Chemotherapy Cancer chemotherapy strives to cause a lethal cytotoxic event or apoptosis in the cancer cells that can arrest

More information

Exhibit B United States Patent Application 20020012663 Kind Code A1 Waksal, Harlan W. January 31, 2002 Treatment of refractory human tumors with epidermal growth factor receptor antagonists Abstract A

More information

through the cell cycle. However, how we administer drugs also depends on the combinations that we give and the doses that we give.

through the cell cycle. However, how we administer drugs also depends on the combinations that we give and the doses that we give. Hello and welcome to this lecture. My name is Hillary Prescott. I am a Clinical Pharmacy Specialist at The University of Texas MD Anderson Cancer Center. My colleague, Jeff Bryan and I have prepared this

More information

Cancer Incidence and Mortality

Cancer Incidence and Mortality Cancer Incidence and Mortality Cancer is a common disease. One in three people in the Western World contract cancer and one in four die from it. The cure rate is 50% Cancer is strongly age-related, the

More information

Anticancer Drugs. Cytotoxic drugs Antineoplastic agents

Anticancer Drugs. Cytotoxic drugs Antineoplastic agents Anticancer Drugs Cytotoxic drugs Antineoplastic agents 1 Principles of Cancer Chemotherapy Cancer chemotherapy strives to cause a lethal cytotoxic event or apoptosis in the cancer cells that can arrest

More information

DRUG PROPERTIES YOU NEED TO KNOW

DRUG PROPERTIES YOU NEED TO KNOW jfitzake@d.umn.edu www.d.umn.edu/~jfitzake Page 1 of 8 DRUG PROPERTIES YOU NEED TO KNOW 1. Mechanism of action a. chemical class b. resistance 2. Pharmacokinetics 3. Therapeutic uses 4. Major side effects/toxicities

More information

ANTI CANCER DRUGS. Dr. Datten Bangun MSc,SpFK. Dept. Farmakologi dan Terapeutik, Fakultas Kedokteran Universitas HKBP Nomensen

ANTI CANCER DRUGS. Dr. Datten Bangun MSc,SpFK. Dept. Farmakologi dan Terapeutik, Fakultas Kedokteran Universitas HKBP Nomensen ANTI CANCER DRUGS Dr. Datten Bangun MSc,SpFK Dept. Farmakologi dan Terapeutik, Fakultas Kedokteran Universitas HKBP Nomensen SITOSTATIKA CYTOSTATICS INTRODUCTION : Cyto : Cells Static : statis Synonim

More information

"Pharmacology. Anticancer Drugs

Pharmacology. Anticancer Drugs I "Pharmacology Anticancer Drugs Include: 1) Cytotoxic drugs. 2) Isotopes: which emit β-irradiation that destroy cancer cells, e.g. I 131, P 32, Au 193 3) Hormones: A- Steroids: prednisolone used in leukemia

More information

Antineoplastic Drugs. Antineoplastic Drugs. Herbal Alert. Pharmacology Chapter 51. Green tea

Antineoplastic Drugs. Antineoplastic Drugs. Herbal Alert. Pharmacology Chapter 51. Green tea Antineoplastic Drugs Pharmacology Chapter 51 Carolyn Wright, RN, BSN Ford, S. & Roach, S. (2010). Roach's introductory clinical pharmacology (9 th ed.). Philadelphia: Wolters Kluwer/Lippincott Williams

More information

DRUG EXTRAVASATION. Vesicants. Irritants

DRUG EXTRAVASATION. Vesicants. Irritants DRUG EXTRAVASATION Vesicants Irritants Vesicants Antineoplastic drugs Amsacrine Dactinomycin Daunorubicin Docetaxel (rare) Doxorubicin Epirubicin Idarubicin Mechlorethamine Mitomycin Oxaliplatin (rare)

More information

Cancer Chemotherapy. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018

Cancer Chemotherapy. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018 Cancer Chemotherapy Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan December 2018 Modalities of Cancer Chemotherapy Curative: Only in 10-15% of cases. In certain disseminated

More information

Lecture 2: DNA cross-linkers and alkylating agents regarded as non-cell cycle specific

Lecture 2: DNA cross-linkers and alkylating agents regarded as non-cell cycle specific Lecture 2: DNA cross-linkers and alkylating agents regarded as non-cell cycle specific Realize that DNA is electron rich and these agents are electron poor ; hence, they react. 1. Platinum agents (we will

More information

Chemotherapy and the development of novel therapeutics

Chemotherapy and the development of novel therapeutics SCPA607-Pathobiology and mechanisms of cancer Chemotherapy and the development of novel therapeutics Somphong Narkpinit, M.D. Department of Pathobiology Faculty of Science Mahidol University E-mail : somphong.nar@mahidol.ac.th

More information

Systemic Treatment of Cancer

Systemic Treatment of Cancer Systemic Treatment of Cancer Irwin H. Krakoff, MD It was demonstrated in the early 1940s that changing the hormonal milieu of certain cancers could result in their regression and that administration of

More information

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites.

Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. WARDS/DEPARTMENTS By: 0 01/09/019 1 of 3 Objective: To provide a standard procedure for the recycling of unused medication and the disposal of medicines across all BCPFT Hospital sites. Scope: All Black

More information

Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and

Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and 35 Adverse effects of anticancer drugs (Antimetabolites agents, Alkylating agents, Antimicrotubule agents, Miscellaneous agents, Immune therapies and Biologically directed therapies ) 1 1- Nausea and vomiting

More information

I. ANTIMETABOLITES. A- Antifolates (Methotrexate, Pemetrexed, and Pralatrexate)

I. ANTIMETABOLITES. A- Antifolates (Methotrexate, Pemetrexed, and Pralatrexate) I. ANTIMETABOLITES Antimetabolites are structurally related to normal cellular components. They generally interfere with the availability of normal purine or pyrimidine nucleotide precursors by inhibiting

More information

Principles of chemotherapy. Ann De Becker Klinische Hematologie UZ Brussel

Principles of chemotherapy. Ann De Becker Klinische Hematologie UZ Brussel Principles of chemotherapy Ann De Becker Klinische Hematologie UZ Brussel History Paul Ehrlich (1854-1915) 1909 Arsphenamine for syphilis treatment Definition: Use of any drug to cure any disease Antineoplastic/cytotoxic

More information

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting

West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting West of Scotland Cancer Network Guideline for Managing Chemotherapy Induced Nausea and Vomiting Definitions Acute nausea and vomiting Delayed nausea and vomiting Anticipatory nausea and vomiting Initial

More information

Cytostatics Definition, Terminology

Cytostatics Definition, Terminology Dept. of Pharmacology, Faculty of Medicine, Masaryk University in Brno Cytostatics Notes for Pharmacology II Practicals This study material is exclusively for students of general medicine and dentistry

More information

Patrick: An Introduction to Medicinal Chemistry 5e Chapter 09

Patrick: An Introduction to Medicinal Chemistry 5e Chapter 09 01) Proflavine is an intercalating agent which was used to treat wounded soldiers in the Far East during the second world war. Which of the following statements is false regarding proflavine? a. It a useful

More information

Principles of chemotherapy

Principles of chemotherapy Principles of chemotherapy Chemotherapy first coined by Paul Ehrlich Aim to selectively destroy cancer cells whilst relatively sparing tumours cells Growth characteristics of cancer cells allows for selective

More information

COST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!!

COST CONSIDERATIONS Union for International Cancer Control 2014 Review of Cancer Medicines on the WHO List of Essential Medicines!!!!!!!!! UICCEMLCostingScenarios BackoftheEnvelope Calculations PreparedforWorkingGroupSession:19621November2014,Geneva MethodsSummary We have chosen a conservative approach, calculating cost per vial. We have

More information

MASCC Guidelines for Antiemetic control: An update

MASCC Guidelines for Antiemetic control: An update MASCC / ISOO 17 th International Symposium Supportive Care in Cancer June 30 July 2, 2005 / Geneva, Switzerland MASCC Guidelines for Antiemetic control: An update Sussanne Börjeson, RN, PhD Linköping University,

More information

Cancer Incidence and Mortality

Cancer Incidence and Mortality Cancer Incidence and Mortality Cancer is a common disease. One in three people in the Western World contract cancer and one in four die from it. The cure rate is 50% Cancer is strongly age-related, the

More information

CANCER CHEMOTHERAPY Michael Lea

CANCER CHEMOTHERAPY Michael Lea CANCER CHEMOTHERAPY 2010 Michael Lea Cancer Chemotherapy - Lecture Outline 1. Targets for cancer chemotherapy 2. Classification of anticancer drugs 3. Cell cycle specificity 4. Drug resistance 5. New approaches

More information

Chemotherapy Teaching Points

Chemotherapy Teaching Points Chemotherapy Teaching Points 1. Antimetabolites - These drugs are analogs of vital co-factors in DNA or RNA synthesis. They competitively inhibit DNA or RNA production, or are directly incorporated into

More information

DRUG PROPERTIES YOU NEED TO KNOW

DRUG PROPERTIES YOU NEED TO KNOW Dr. Janet Fitzakerley Summer 2013 Med 6541 Hematopoiesis and Host Defences jfitzake@d.umn.edu www.d.umn.edu/~jfitzake Page 1 of 11 DRUG PROPERTIES YOU NEED TO KNOW 1. Mechanism of action a. chemical class

More information

Essentials. Oncology Practise Essentials. Oncology Basics. Tutorial 2. Cancer Chemotherapy

Essentials. Oncology Practise Essentials. Oncology Basics. Tutorial 2. Cancer Chemotherapy Practise Practise This tutorial introduces you to the history, goals of therapy, classification, and clinical uses of chemotherapy. It also reviews some of the barriers to successful therapy. Goals and

More information

Fundamentals of Pharmacology for Veterinary Technicians Chapter 20

Fundamentals of Pharmacology for Veterinary Technicians Chapter 20 Figure 20-1 Figure 20-2 Figure 20-3A Figure 20-3B Figure 20-4 Table 20-1 Antineoplastic Agents Used for Chemotherapy in Animals Drug Type Drug Category Examples Cell-Cycle Effect CCNS Alkylating agents:

More information

Cancer SLO Practice (online set) Page 1 of 5

Cancer SLO Practice (online set) Page 1 of 5 Cancer SLO Practice (online set) Page 1 of 5 1. Aranesp is? A. Darbepoetin alfa B. Filgrastim C. Epoetin alfa D. Sargramostim E. Pegfilgrastim 2. BCNU is? B. Cyclophosphamide 3. Bleomycin is a natural

More information

*Combination therapy: *Cancer drugs are divided into groups: I) DNA binding agents (Intercalating and Alkylating agents) 2 types: Doxorubicin

*Combination therapy: *Cancer drugs are divided into groups: I) DNA binding agents (Intercalating and Alkylating agents) 2 types: Doxorubicin *Combination therapy: - Cancer is heterogeneous, and resistant anticancer drugs are common, so combination of drugs together is needed in order to attack cancer. *Cancer drugs are divided into groups:

More information

Choice of Cancer Chemotherapy u Is it a science, art or voodoo medicine?

Choice of Cancer Chemotherapy u Is it a science, art or voodoo medicine? PRINCIPLES OF CYTOTOXIC CHEMOTHERAPY Dr.Erdem Göker Ege Üniversitesi Tıp Fakültesi TÜLAY AKTAŞ ONKOLOJİ HASTANESİ Choice of Cancer Chemotherapy u Is it a science, art or voodoo medicine? BEST Tx OF CANCER

More information

Lecture 3: Antimetabolites cell cycle specific (S-phase) 1. Folate analogs

Lecture 3: Antimetabolites cell cycle specific (S-phase) 1. Folate analogs Lecture 3: Antimetabolites cell cycle specific (S-phase) All the antimetabolites mimic endogenous molecules. They trick enzymes involved in the synthesis of DNA, and instead of metabolizing the proper

More information

Pharmacology. Cell cycle

Pharmacology. Cell cycle Objectives: To define chemotherapy To define the common classes of drugs used and mechanism of action To identify dermatologic side effects of chemotherapeutic drugs Chemotherapy Definition: the treatment

More information

ASSESSMENT OF THE PAEDIATRIC NEEDS CHEMOTHERAPY PRODUCTS (PART I) DISCLAIMER

ASSESSMENT OF THE PAEDIATRIC NEEDS CHEMOTHERAPY PRODUCTS (PART I) DISCLAIMER European Medicines Agency Evaluation of Medicines for Human Use London, September 2006 Doc. Ref.: EMEA/384641/2006 ASSESSMENT OF THE PAEDIATRIC NEEDS CHEMOTHERAPY PRODUCTS (PART I) DISCLAIMER The Paediatric

More information

Female Health Issues after Treatment for Childhood Cancer

Female Health Issues after Treatment for Childhood Cancer Female Health Issues after Treatment for Childhood Cancer The effects of childhood cancer therapy on female reproductive function depend on many factors, including the girl s age at the time of cancer

More information

Index. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.

Index. derm.theclinics.com. Note: Page numbers of article titles are in boldface type. Note: Page numbers of article titles are in boldface type. A Acitretin and cutaneous T-cell lymphomas, 716 719, 722, 725 ADCC. See Antibody-dependent cell-mediated cytotoxicity. Adjunctive therapies and

More information

Hospice Skills Checklist

Hospice Skills Checklist _ XXX-XX- Print Name Last 4 of SS # Date Completed Directions Please circle a value for each question to provide us and the interested facilities with an assessment of your clinical experience. These values

More information

Oncology Skills Checklist

Oncology Skills Checklist _ XXX-XX- Print Name Last 4 of SS # Date Completed Directions Please circle a value for each question to provide us and the interested facilities with an assessment of your clinical experience. These values

More information

Lecture 4: Antimetabolites cell cycle specific (S-phase) 1. Folate analogs

Lecture 4: Antimetabolites cell cycle specific (S-phase) 1. Folate analogs Lecture 4: Antimetabolites cell cycle specific (S-phase) All the antimetabolites mimic endogenous molecules. They trick enzymes involved in the synthesis of DA, and instead of metabolizing the proper endogenous

More information

Emetogenicity level 1. Emetogenicity level 2

Emetogenicity level 1. Emetogenicity level 2 Emetogenicity level 1 15 mins Pre-Chemo Maxalon 10mg po During chemo and Post Chemo 3 days Maxalon10mg po 8 hourly Increase Maxalon 20mg po 8 hourly Change to Cyclizine 50mg po 8 hourly 3 days If nausea

More information

1 The Cancer Programs Regulation (AR 242/98) is amended by this Regulation.

1 The Cancer Programs Regulation (AR 242/98) is amended by this Regulation. Alberta Regulation 18/2005 Cancer Programs Act AMENDMENT REGULATION Filed: February 22, 2005 For information only: Made by the Minister of Health and Wellness (M.O. 9/2005) on February 17, 2005 pursuant

More information

Why do patients take herbs and nutritional supplements?

Why do patients take herbs and nutritional supplements? Why do patients take herbs and nutritional supplements? Dissatisfaction with conventional medicine > Relieve cancer-related symptoms > Treat adverse effects of anticancer drugs > Treat cancer > Promote

More information

Intro to Cancer Therapeutics

Intro to Cancer Therapeutics An Intro to Cancer Therapeutics Christopher R. Chitambar, MD Professor of Medicine Division of Hematology & Oncology Froedtert and Medical College of Wisconsin Clinical Cancer Center cchitamb@mcw.edu Intro

More information

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION

GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY CLASSIFICATION GUIDELINES FOR ANTIEMETIC USE IN ONCOLOGY SUMMARY More than half of all cancer patients experience nausea or vomiting during the course of their treatment. If nausea or vomiting becomes severe enough,

More information

Patient 1: Patient 2:

Patient 1: Patient 2: Appendix A Compiled by Dr. Raymond Ngeh and Dr. Robert Luk Clinical notes and PET/CT scan images of eleven patients: 1. Middle age woman has cancer of the pancreas in the body of the gland. After just

More information

NUCLEOTIDE METABOLISM

NUCLEOTIDE METABOLISM NUCLEOTIDE METABOLISM Purine and pyrimidine. The atoms are numbered according to the international system. Tautomerism of the oxo and amino functional groups of purines and pyrimidines. POLYNUCLEOTIDES

More information

Antineoplastic Agents

Antineoplastic Agents 56 Antineoplastic Agents Branimir I. Sikic DRUG LIST GENERIC NAME PAGE GENERIC NAME PAGE Aldesleukin 652 Asparaginase 649 Bleomycin 647 Buserelin 650 Busulfan 642 Carboplatin 652 Carmustine 641 Chlorambucil

More information

DRUGS FOR NEOPLASIA. Chapter 37

DRUGS FOR NEOPLASIA. Chapter 37 DRUGS FOR NEOPLASIA Chapter 37 Keywords- You tell Me! Cancer dz characterized by abnormal, uncontrolled cell division Tumor swelling, abnormal enlargement or mass of tissue Carcinogen any substance or

More information

Introduction to Antineoplastic Prescribing

Introduction to Antineoplastic Prescribing Introduction to Antineoplastic Prescribing Robert Bradbury, R.Ph., BCPS Clinical Coordinator H. Lee Moffitt Cancer Center Objectives Meet the following goals concerning antineoplastic prescribing: Understand

More information

An introduction to the Essential Medicines concept: balancing innovation with public health priorities

An introduction to the Essential Medicines concept: balancing innovation with public health priorities An introduction to the Essential Medicines concept: balancing innovation with public health priorities WHO HQ, Geneva 11 October 2017 Nicola Magrini Secretary, WHO Expert Committee on the Selection and

More information

Metabolism of Nucleotides

Metabolism of Nucleotides Metabolism of Nucleotides Outline Nucleotide degradation Components of Nucleobases Purine and pyrimidine biosynthesis Hyperuricemia Sources Nucleotide degradation The nucleotides are among the most complex

More information

It is a malignancy originating from breast tissue

It is a malignancy originating from breast tissue 59 Breast cancer 1 It is a malignancy originating from breast tissue including both early stages which are potentially curable, and metastatic breast cancer (MBC) which is usually incurable. Most breast

More information

The problem. The treatment. Special situations. Brief background on HBV Definitions of HBV reactivation. The role and timing of antiviral therapy

The problem. The treatment. Special situations. Brief background on HBV Definitions of HBV reactivation. The role and timing of antiviral therapy Pr Raymond Sayegh The problem Brief background on HBV Definitions of HBV reactivation The treatment The role and timing of antiviral therapy Special situations Lone anti-hbcpositive, rituximab, BMT, reactivation

More information

Elements for a Public Summary. Overview of Disease Epidemiology

Elements for a Public Summary. Overview of Disease Epidemiology VI.2 VI.2.1 Elements for a Public Summary Overview of Disease Epidemiology Toxicity of Folic acid antagonists Despite having a low frequency of major toxicity, low dose Methotrexate (MTX, folic acid antagonist)

More information

Nucleotide Metabolism. Pyrimidine Met. Purine Met.

Nucleotide Metabolism. Pyrimidine Met. Purine Met. Nucleotide Metabolism Pyrimidine Met. Purine Met. Learning Objectives 1. How Are Purines Synthesized? 2. How Are Purines Catabolized? 3. How Are Pyrimidines Synthesized and Catabolized? 4. How Are Ribonucleotides

More information

Signal Transduction. & Mechanisms of Drug Action

Signal Transduction. & Mechanisms of Drug Action Signal Transduction & Mechanisms of Drug Action Why do some drugs produce effects that persist for long after the drug is no longer present? Why do response to other drugs diminish rapidly with repeated

More information

Lecture 10: Antimetabolites cell cycle specific (S-phase)

Lecture 10: Antimetabolites cell cycle specific (S-phase) Lecture 10: Antimetabolites cell cycle specific (S-phase) bjectives: 1. Be able to explain the general mechanism of action of antimetabolites 2. Understand the specific mechanisms of the folate analogs

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Hepatitis B virus and solid organ transplantation Prof. Hakan Leblebicioglu Department of Clinical Microbiology and Infectious Diseases Ondokuz Mayis University, Samsun, Turkey Conflict of interest Outline

More information

Chemotherapy and its side effects.

Chemotherapy and its side effects. Chemotherapy and its side effects. Maria Ronson Lead Chemotherapy Nurse Learning outcomes How it works on cells terminology. Understand and learn about side effects of chemotherapy. Management of side

More information

It is an abnormal mass (growth) of body tissues, it may be

It is an abnormal mass (growth) of body tissues, it may be 1 What is cancer? It is uncontrolled growth of abnormal cells in the body due to genetic mutation and/or lack of control mechanisms that govern cell proliferation & differentiation. Normally immune system

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Immunosuppression and Hepatitis B Virus Reactivation Prof. Hakan Leblebicioglu, MD hakan@omu.edu.tr www.leblebicioglu.org Immunotolerance Immune Clearance HBV reactivation HBeAg+ HBeAg- HBeAb+ HBV DNA

More information

FOR A HIGHER DEGREE OF CONFIDENCE

FOR A HIGHER DEGREE OF CONFIDENCE SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS. > Introduction Manufacturing specialized products in a pharmaceutical manufacturing environment has a specific set of requirements

More information

Answer ALL questions. For each question, there is ONE correct answer. Use the answer grid provided for ALL your answers.

Answer ALL questions. For each question, there is ONE correct answer. Use the answer grid provided for ALL your answers. UNIVERSITY OF EAST ANGLIA School of Pharmacy Main Series UG Examination 2013-2014 CLINICAL THERAPEUTICS 8: ONCOLOGY PHA-MHCY Time allowed: 2 hours Part ONE Answer ALL questions. For each question, there

More information

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients

Guidelines on Chemotherapy-induced Nausea and Vomiting in Pediatric Cancer Patients Guidelines on Chemotherapy-induced Nausea Vomiting in Pediatric Cancer Patients COG Supportive Care Endorsed Guidelines Click here to see all the COG Supportive Care Endorsed Guidelines. DISCLAIMER For

More information

Vasco OP Underglove Sterile Surgical and Protective Gloves

Vasco OP Underglove Sterile Surgical and Protective Gloves data sheet EN 374:2003 EN 374:2003 AQL 0.65 B. Braun Melsungen AG confirms that Vasco OP Underglove gloves comply with the following standards and directives: EC CERTIFICATES AND Applied standards Medical

More information

Leucovorin Calcium Tablets USP, 5 mg, 10 mg, 15 mg, and 25 mg

Leucovorin Calcium Tablets USP, 5 mg, 10 mg, 15 mg, and 25 mg Leucovorin Calcium Tablets USP, 5 mg, 10 mg, 15 mg, and 25 mg Rx only DESCRIPTION Leucovorin Calcium Tablets USP contain either 5 mg, 10 mg, 15 mg or 25 mg leucovorin as the calcium salt of N-[4-[[(2-amino-5-formyl-1,4,5,6,7,8-hexahydro-4-oxo-6-pteridinyl)methyl]

More information

SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS

SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS SELECTING THE RIGHT HAND PROTECTION WHEN WORKING WITH CHEMOTHERAPY DRUGS Manufacturing specialized products in a pharmaceutical

More information

Lecture 16: Therapeutics to Treat Cancer

Lecture 16: Therapeutics to Treat Cancer Lecture 16: Therapeutics to Treat Cancer Therapeutic Objectives Primary prevention stop the risk of cancer before it occurs o Smoking cessation o Coxibs COX2 selective cyclooxygenase inhibitor PGE2 facilitates

More information

Cisplatin and Gemcitabine (bladder)

Cisplatin and Gemcitabine (bladder) Cisplatin and Gemcitabine (bladder) Indication Palliative therapy for locally advanced or metastatic bladder cancer in patients with good renal function. Palliative therapy for urothelial transitional

More information

3.11 Combination chemotherapy CHOP ABVD MOPP BEAM 4. Radiotherapy 4.1 Cranial irradiation 4.2 Cranial irradiation>18gy

3.11 Combination chemotherapy CHOP ABVD MOPP BEAM 4. Radiotherapy 4.1 Cranial irradiation 4.2 Cranial irradiation>18gy Late Effects of Cancer Treatment Screening and Surveillance Guidelines for GPs Peter MacCallum Cancer Centre Late Effects Service July 2011 Adapted from the Children s Oncology Group Long-Term Follow-Up

More information

DOXOrubicin, Cyclophosphamide (AC 60/600) 21 day followed by weekly PACLitaxel (80) Therapy (AC-T) 261 CARBOplatin (AUC4-6) Monotherapy-21 days

DOXOrubicin, Cyclophosphamide (AC 60/600) 21 day followed by weekly PACLitaxel (80) Therapy (AC-T) 261 CARBOplatin (AUC4-6) Monotherapy-21 days Last updated Oct 17, 2018 Tumour Group Protocol Number Protocol Name on NCCP website Breast 200 Trastuzumab (IV) Monotherapy 21 days 201 Trastuzumab (IV) Monotherapy 7 days 202 DOCEtaxel Monotherapy 100mg/m2

More information

Guidelines for the Use of Anti-Emetics with Chemotherapy

Guidelines for the Use of Anti-Emetics with Chemotherapy Guidelines for the Use of Anti-Emetics with The purpose of this document is to provide guidance on the rational use of anti-emetics for prevention and treatment of chemotherapy-induced nausea and vomiting

More information

Chemotherapeutics. Andrew Stolbach

Chemotherapeutics. Andrew Stolbach Chemotherapeutics Andrew Stolbach Principles of Chemotherapy Cytotoxic therapy Damage DNA Interfere with formation of mitotic spindle Targeted therapy Hormonal Antibody Growth Factor inhibition Focus Your

More information

CANCER PREVENTION AND ACCESS TO MEDICINES. Gracemarie Bricalli ESMO Head of International Affairs

CANCER PREVENTION AND ACCESS TO MEDICINES. Gracemarie Bricalli ESMO Head of International Affairs CANCER PREVENTION AND ACCESS TO MEDICINES Gracemarie Bricalli ESMO Head of International Affairs ESMO s 2020 Vision: Access to cancer care ESMO s 2020 vision statement recognises that progress in the management

More information

Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy

Protocol Number Tumour Group Protocol Name on NCCP website 22/02/ Lung Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy Last Updated 22-Feb-18 Date of last update Protocol Number Tumour Group Protocol Name on NCCP website 22/02/2018 221 Afatinib Monotherapy 244 Gastrointestinal Regorafenib Monotherapy 249 Gynaecology Intrathecal

More information

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY

BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Cancer is a group of more than 100 different diseases that are characterized by uncontrolled cellular growth,

More information

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies:

VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Etiologies: VI.2 Elements for a Public Summary VI.2.1 Overview of Disease Epidemiology Acute Nausea and Vomiting (N&V) Incidence: The incidence of acute and delayed N&V was investigated in highly and moderately emetogenic

More information

1 HST-151. Principles of Clinical Cancer Chemotherapy and Drug Resistance

1 HST-151. Principles of Clinical Cancer Chemotherapy and Drug Resistance 1 HST-151 Principles of Clinical Cancer Chemotherapy and Drug Resistance Cancer Mortality: 2000 = 553,091; Est.2003 = 556,500 Cancer Chemotherapy -- Effectiveness by Disease 1. Curative Acute Lymphocytic

More information

Stem cell transplantation. Dr Mohammed Karodia NHLS & UP

Stem cell transplantation. Dr Mohammed Karodia NHLS & UP Stem cell transplantation Dr Mohammed Karodia NHLS & UP The use of haemopoeitic stem cells from a donor harvested from peripheral blood or bone marrow, to repopulate recipient bone marrow. Allogeneic From

More information

18th Expert Committee on the Selection and Use of Essential Medicines. Reviewer No. 1 checklist for:

18th Expert Committee on the Selection and Use of Essential Medicines. Reviewer No. 1 checklist for: 18th Expert Committee on the Selection and Use of Essential Medicines Reviewer No. 1 checklist for: Review of medicines for the treatment of common tumours in Children In the WHO Essential Medicines List

More information

Calcium folinate as equivalent to folinic acid 50 mg/5 ml, 100 mg/10 ml COO - Ca2+, xh2o CH 2

Calcium folinate as equivalent to folinic acid 50 mg/5 ml, 100 mg/10 ml COO - Ca2+, xh2o CH 2 Product Information LEUCOVORIN CALCIUM INJECTION Calcium folinate as equivalent to folinic acid 50 mg/5 ml, 100 mg/10 ml NAME OF THE MEDICINE Non-proprietary name: calcium folinate Chemical name: calcium

More information

(R) CODOX M / (R) IVAC

(R) CODOX M / (R) IVAC (R) CODOX M / (R) IVAC Indication Burkitt's or Burkitt's-like lymphoma, especially those with 1 or more of the following poor risk criteria: - Raised LDH level - WHO performance status 2-4 - Ann Arbor

More information

Vasco OP Free Sterile Surgical and Protective Gloves

Vasco OP Free Sterile Surgical and Protective Gloves DATA SheeT EN 374:2003 EN 374:2003 AQl 0.65 B. Braun Melsungen AG confirms that Vasco OP Free gloves comply with the following standards and directives: ec certificates AnD APPlieD STAnDArDS Medical device

More information

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST

THE CLATTERBRIDGE CANCER CENTRE NHS FOUNDATION TRUST Outpatient Anti Cancer Treatment Handbook LCV Lomustine, Cisplatin, Vincristine Packer Regimen Repeated every 6 weeks for a maximum of 6 cycles Approved for use in: Medulloblastoma adjuvant therapy Dosage:

More information

Vasco OP Sensitive Sterile Surgical and Protective Gloves

Vasco OP Sensitive Sterile Surgical and Protective Gloves data sheet EN 374:2003 EN 374:2003 AQL 0.65 B. Braun Melsungen AG confirms that Vasco OP Sensitive gloves comply with the following standards and directives: EC CERTIFICATES AND Applied standards Medical

More information

Nutrition and oncology: medical aspects. Case history. What is cancer? Head, Palliative Care RPAH/Sydney Cancer Centre May 2008

Nutrition and oncology: medical aspects. Case history. What is cancer? Head, Palliative Care RPAH/Sydney Cancer Centre May 2008 utrition and oncology: medical aspects? Clin Assoc Prof. Paul Glare, FRACP Head, Palliative Care RPAH/Sydney Cancer Centre May 2008 Case history What is cancer? 24M PH IDU, HCV 1/08: bowel obstruction:

More information

Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249

Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249 Last updated Feb 9, 2018 Revision due Protocol Name on NCCP website Tumour Group Protocol Number Intrathecal Methotrexate for CNS 01/02/2018 Prophylaxis in GTN Gynaecology 249 Two Day Etoposide CISplatin

More information

IMPROVING CHEMOTHERAPY AND ITS PROTOCOLS TUMOUR TYPES

IMPROVING CHEMOTHERAPY AND ITS PROTOCOLS TUMOUR TYPES Vet Times The website for the veterinary profession https://www.vettimes.co.uk IMPROVING CHEMOTHERAPY AND ITS PROTOCOLS TUMOUR TYPES Author : Frances Taylor Categories : Vets Date : August 29, 2011 Frances

More information

Folic Acid and vitamin B12

Folic Acid and vitamin B12 Folic Acid and vitamin B12 ILOs: by the end of this lecture, you will be able to: 1. Understand that vitamins are crucial nutrients that are important to health. 2. Know that folic acid and vitamin B12

More information

VIP (Etoposide, Ifosfamide and Cisplatin)

VIP (Etoposide, Ifosfamide and Cisplatin) VIP (Etoposide, Ifosfamide and Cisplatin) Indication First line treatment for metastatic seminoma, non seminoma or combined tumours where bleomycin is contra-indicated. Usually used for patients with intermediate

More information

What s a Transplant? What s not?

What s a Transplant? What s not? What s a Transplant? What s not? How to report the difference? Daniel Weisdorf MD University of Minnesota Anti-cancer effects of BMT or PBSCT [HSCT] Kill the cancer Save the patient Restore immunocompetence

More information

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced

ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced ICON Formulary - October 2018 Legend - ICON Protocols Essential (previously Standard), Core, Enhanced Core, Enhanced Enhanced Class Medicine Name Nappi Strength Form Size Route Abiraterone Acetate ZYTIGA

More information